Rani Therapeutics 与日本中外制药签订价值 10.9 亿美元的许可协议

路透中文
Oct 17
Rani <a href="https://laohu8.com/S/LENZ">Therapeutics</a> 与日本中外制药签订价值 10.9 亿美元的许可协议

路透社10月17日 - Rani Therapeutics RANI.O周五表示,该公司已同意向日本中外制药4519.T授权一种口服药物,并可选择将授权范围扩大到最多五种药物,交易总价值可能达到10.9亿美元。

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10